OECs transplantation	1
neuropathic pain associated with BDNF regulating ERK activity in rats following cord hemisection Bing-Chen Lang1	33
neuropathic pain	33
BDNF regulating ERK activity in rats following cord hemisection Bing-Chen Lang1	66
BDNF	66
ERK activity	82
rats following cord hemisection Bing-Chen Lang1	98
rats	98
cord hemisection Bing-Chen Lang1	113
,2 † , Zhuo Zhang4 † , Long-Yun Lv3 , Jin Liu2 , Ting-Yong Wang3 , Ling-Hui Yang2 , Da-Qing Liao2 , Wen-Sheng Zhang2 *	146
,2 † , Zhuo Zhang4 † , Long-Yun Lv3 , Jin Liu2 , Ting-Yong Wang3 , Ling-Hui Yang2 , Da-Qing Liao2 , Wen-Sheng Zhang2	146
,2 †	146
Zhuo Zhang4 †	151
Long-Yun Lv3	165
Jin Liu2	179
Ting-Yong Wang3	189
Ling-Hui Yang2	206
Da-Qing Liao2	222
Wen-Sheng Zhang2	237
Ting-Hua	259
Wang2 ,3,5	268
Abstract Background : The olfactory ensheathing cells -LRB- OECs -RRB- derived from olfactory bulb -LRB- OB -RRB-	280
Abstract Background	280
The olfactory ensheathing cells -LRB- OECs -RRB- derived from olfactory bulb -LRB- OB -RRB-	301
The olfactory ensheathing cells -LRB- OECs -RRB-	301
The olfactory ensheathing cells	301
OECs	334
olfactory bulb -LRB- OB -RRB-	353
olfactory bulb	353
OB	369
motor function	385
transplantation in injured spinal cord	406
transplantation	406
injured spinal cord	425
the effects of OEC transplantation on sensory function	455
the effects	455
OEC transplantation on sensory function	470
OEC transplantation	470
sensory function	493
The purpose of this study	538
The purpose	538
this study	553
OEC transplantation	590
the sensory function	623
the underlying mechanism	659
Results : OEC transplantation into the hemisected spinal cords can result in hyperalgesia , indicated by radiant and mechanical stimuli towards the plantar surface in rats .	685
Results	685
OEC transplantation into the hemisected spinal cords	694
OEC transplantation	694
the hemisected spinal cords	719
hyperalgesia , indicated by radiant and mechanical stimuli towards the plantar surface in rats	761
hyperalgesia	761
radiant and mechanical stimuli	788
the plantar surface in rats	827
the plantar surface	827
rats	850
This	856
upregulation of Brain Derived Neurotrophic Factor -LRB- BDNF -RRB- , indicated by RT-PCR	886
upregulation	886
Brain Derived Neurotrophic Factor -LRB- BDNF -RRB- , indicated by RT-PCR	902
Brain Derived Neurotrophic Factor -LRB- BDNF -RRB-	902
Brain Derived Neurotrophic Factor	902
BDNF	937
RT-PCR	957
Immunofluorecent staining	965
BDNF	1003
the neurons of the laminas I and II of the dorsal horn	1030
the neurons	1030
the laminas I and II of the dorsal horn	1045
the laminas I	1045
the laminas	1045
I	1057
II of the dorsal horn	1063
II	1063
the dorsal horn	1069
a notable upregulation on the level of p-ERK -LRB- phosphorylation of extracellular signal-regulated kinase -RRB- , the downstream molecule of BDNF ,	1096
a notable upregulation	1096
the level	1122
p-ERK	1135
phosphorylation of extracellular signal-regulated kinase	1142
phosphorylation	1142
extracellular signal-regulated kinase	1161
the downstream molecule of BDNF	1201
the downstream molecule	1201
BDNF	1228
Western Blot	1256
These findings	1270
the increased BDNF level associated with the p-ERK	1299
the increased BDNF level	1299
the p-ERK	1340
neuropathic pain	1375
hemisected spinal cord subjected to OEC transplantation	1395
hemisected spinal cord	1395
OEC transplantation	1431
Conclusions : The transplantation of OECs may induce the noticeable pain hypersensitivity in rats after hemisected spinal cord injury , and the possible mechanism may be associated with the phosphorylation of ERK and the activated BDNF overexpression .	1452
Conclusions	1452
The transplantation of OECs	1465
The transplantation	1465
OECs	1488
the noticeable pain hypersensitivity in rats	1504
the noticeable pain hypersensitivity	1504
rats	1544
hemisected spinal cord injury	1555
the possible mechanism	1590
the phosphorylation of ERK and the activated BDNF overexpression	1636
the phosphorylation	1636
ERK and the activated BDNF overexpression	1659
ERK	1659
the activated BDNF overexpression	1667
Background To make the neuronal regeneration to eventual functional recovery after spinal cord injury -LRB- SCI -RRB- , various treatments including surgical , pharmacological , and neurophysiologic approaches	1703
the neuronal regeneration	1722
eventual functional recovery	1751
spinal cord injury -LRB- SCI -RRB- , various treatments including surgical , pharmacological , and neurophysiologic approaches	1786
spinal cord injury -LRB- SCI -RRB-	1786
spinal cord injury	1786
SCI	1806
various treatments including surgical , pharmacological , and neurophysiologic approaches	1812
various treatments	1812
surgical , pharmacological , and neurophysiologic approaches	1841
cell transplantation with hypotoxicity and high effectiveness	1933
cell transplantation	1933
hypotoxicity and high effectiveness	1959
a promising strategy for the treatment of SCI	2004
a promising strategy	2004
the treatment of SCI	2029
the treatment	2029
SCI	2046
a special type of neuroglial cells derived from the olfactory bulb	2054
a special type	2054
neuroglial cells derived from the olfactory bulb	2072
neuroglial cells	2072
the olfactory bulb	2102
olfactory ensheathing cells -LRB- OECs -RRB- ,	2122
olfactory ensheathing cells	2122
OECs	2151
the permanent function of neural regeneration	2171
the permanent function	2171
neural regeneration	2197
the Schwann cells	2232
the OEC	2251
higher migration ability and higher ability of integration with nerve axons and other neuroglial cells -LSB- 1-3 -RSB-	2267
higher migration ability and higher ability of integration with nerve axons	2267
higher migration ability	2267
higher ability of integration with nerve axons	2296
higher ability	2296
integration with nerve axons	2314
integration	2314
nerve axons	2331
other neuroglial cells -LSB- 1-3 -RSB-	2347
other neuroglial cells	2347
1-3 -RSB-	2371
OECs	2389
various neurotrophins such as platelet derivation growth factor -LRB- PDGF -RRB- , brain-derived neurotrophic factor -LRB- BDNF -RRB- -LSB- 4,5 -RSB- , nerve growth factor -LRB- NGF -RRB- -LSB- 6 -RSB- and neurotrophin-4 / 5 -LSB- 7 -RSB-	2406
various neurotrophins	2406
platelet derivation growth factor -LRB- PDGF -RRB- , brain-derived neurotrophic factor -LRB- BDNF -RRB- -LSB- 4,5 -RSB- , nerve growth factor -LRB- NGF -RRB- -LSB- 6 -RSB- and neurotrophin-4 / 5 -LSB- 7 -RSB-	2436
platelet derivation growth factor -LRB- PDGF -RRB-	2436
platelet derivation growth factor	2436
PDGF	2471
brain-derived neurotrophic factor -LRB- BDNF -RRB-	2478
brain-derived neurotrophic factor	2478
BDNF	2513
4,5 -RSB-	2520
nerve growth factor -LRB- NGF -RRB-	2526
nerve growth factor	2526
NGF	2547
6 -RSB-	2553
neurotrophin-4 / 5 -LSB- 7 -RSB-	2560
neurotrophin-4	2560
5 -LSB- 7	2575
an injured spinal cord	2585
the transplanted OECs	2609
a neuroprotective effect on descending cortical and brain stem neurons -LSB- 8,9 -RSB-	2636
a neuroprotective effect	2636
cortical and brain stem neurons -LSB- 8,9 -RSB-	2675
cortical and brain stem neurons	2675
8,9 -RSB-	2708
the effect of OECs on the improvement of motor function	2725
the effect	2725
OECs on the improvement of motor function	2739
OECs	2739
the improvement of motor function	2747
the improvement	2747
motor function	2766
it	2791
the treatment of OEC transplantation	2819
the treatment	2819
OEC transplantation	2836
the sensory function	2875
this experiment	2900
the mechanical and thermal hyperalgesia behaviors of rats with hemisected spinal cord injury -LRB- hSCI -RRB-	2917
the mechanical and thermal hyperalgesia behaviors	2917
rats with hemisected spinal cord injury -LRB- hSCI -RRB-	2970
rats	2970
hemisected spinal cord injury -LRB- hSCI -RRB-	2980
hemisected spinal cord injury	2980
hSCI	3011
OEC transplantation	3037
we	3063
the underlying mechanism , which would be correlated with the phosphorylation of ERK and the upregulation of BDNF	3075
the underlying mechanism	3075
the phosphorylation of ERK and the upregulation of BDNF	3132
the phosphorylation of ERK	3132
the phosphorylation	3132
ERK	3155
the upregulation of BDNF	3163
the upregulation	3163
BDNF	3183
Results Table 1 Numbers of animal in each group Figure 1 Identification of OECs in vitro .	3190
Results	3190
Table 1 Numbers of animal in each group Figure	3198
Table 1 Numbers	3198
animal in each group Figure	3217
animal	3217
each group Figure	3227
1 Identification of OECs in vitro	3246
1 Identification	3246
OECs in vitro	3266
OECs	3266
The cultured OECs	3281
The	3281
OECs	3294
in A	3310
The cells	3316
positive brown staining	3336
neurotrophin surface receptor p75	3364
B , Brown staining	3399
B	3399
Brown staining	3402
DAB	3422
The GFP-OECs cells which emitting green fluorescence	3428
The GFP-OECs cells	3428
green fluorescence	3462
C	3494
the red fluorescence	3513
the GFP cells	3549
p75 -LRB- D -RRB-	3575
p75	3575
D	3580
Figure 2 Evaluations on Nociceptive Tests .	3585
Figure	3585
2 Evaluations on Nociceptive Tests	3592
2 Evaluations	3592
Nociceptive Tests	3609
the nociceptive evaluation of thermal stimuli	3631
the nociceptive evaluation	3631
thermal stimuli	3661
these asterisks	3678
the left paw withdrawal latency -LRB- PWL -RRB- of the OEC transplantation group	3708
the left paw withdrawal latency -LRB- PWL -RRB-	3708
the left paw withdrawal latency	3708
PWL	3741
the OEC transplantation group	3749
those of the injury group -LRB- * P < 0.05 -RRB- and the sham group -LRB- *** P < 0.001 -RRB-	3808
those	3808
the injury group -LRB- * P < 0.05 -RRB- and the sham group -LRB- *** P < 0.001 -RRB-	3817
the injury group	3817
P <	3836
P	3836
<	3838
0.05	3840
the sham group	3850
*** P < 0.001	3866
*** P	3866
< 0.001	3871
<	3871
0.001	3873
A	3881
the nociceptive evaluation of thermal stimuli	3888
the nociceptive evaluation	3888
thermal stimuli	3918
the left paw withdrawal thresholds -LRB- PWT -RRB- of sham group	3935
the left paw withdrawal thresholds -LRB- PWT -RRB-	3935
the left paw withdrawal thresholds	3935
PWT	3971
sham group	3979
those of the injury group -LRB- *** P < 0.001 -RRB-	4021
those	4021
the injury group -LRB- *** P < 0.001 -RRB-	4030
the injury group	4030
*** P < 0.001	4048
*** P	4048
< 0.001	4053
<	4053
0.001	4055
the PWTs of the OEC transplantation group	4069
the PWTs	4069
the OEC transplantation group	4081
the sham group -LRB- *** P < 0.001 -RRB- -LRB- B -RRB-	4139
the sham group -LRB- *** P < 0.001 -RRB-	4139
the sham group	4139
*** P < 0.001	4155
*** P	4155
< 0.001	4160
<	4160
0.001	4162
B	4170
Figure 3 Survival and migrating of OECs in vivo , and localization of BDNF .	4175
Figure 3 Survival and migrating	4175
Figure 3 Survival	4175
migrating	4197
OECs in vivo , and localization of BDNF	4210
OECs in vivo	4210
OECs	4210
vivo	4218
localization of BDNF	4228
localization	4228
BDNF	4244
the situation of injured control group -LRB- B -RRB- , implanted	4264
the situation	4264
injured control group -LRB- B -RRB- , implanted	4281
injured control group -LRB- B -RRB-	4281
injured control group	4281
B	4304
OECs	4318
the capability of surviving in the injured spinal cord after implantation -LRB- A -RRB-	4327
the capability	4327
the injured spinal cord	4358
implantation -LRB- A -RRB-	4388
implantation	4388
A	4402
The OEC with green fluorescence around the site of injury	4406
The OEC	4406
green fluorescence around the site of injury	4419
green fluorescence	4419
the site of injury	4445
the site	4445
injury	4457
C	4479
the transplanted cells	4493
spinal cord	4545
one month after injury	4562
one month	4562
injury	4578
neurons in the dorsal horn	4602
neurons	4602
the dorsal horn	4613
BDNF , which emit red fluorescence -LRB- D-F -RRB-	4643
BDNF	4643
red fluorescence -LRB- D-F -RRB-	4659
red fluorescence	4659
D-F	4677
The quantitative analysis	4683
G. Figure	4723
4 Identification of BDNF expression in transplanted OECs and host neurons	4734
4 Identification	4734
BDNF expression in transplanted OECs and host neurons	4754
BDNF expression	4754
transplanted OECs and host neurons	4773
The distribution of nucleus	4809
The distribution	4809
nucleus	4829
DAPI staining	4856
It	4871
OECs	4889
BDNF	4906
transplantation -LRB- A-D -RRB-	4917
transplantation	4917
A-D	4934
the images	4951
the BDNF expression	4979
neurons -LRB- E-H -RRB-	5029
neurons	5029
E-H	5038
these neurons	5050
co-expresseion of TrkB receptor -LRB- I-L -RRB-	5068
co-expresseion	5068
TrkB receptor -LRB- I-L -RRB-	5086
TrkB receptor	5086
I-L	5101
Figure 5 mRNA changes of BDNF in RT-PCR .	5108
Figure	5108
5 mRNA changes of BDNF in RT-PCR	5115
5 mRNA changes	5115
BDNF in RT-PCR	5133
BDNF	5133
RT-PCR	5141
OECs transplantation	5149
the BDNF expression	5195
the 21th day ininjured spinal cord after OEC transplantation -LRB- A -RRB-	5218
the 21th day	5218
spinal cord	5241
OEC transplantation -LRB- A -RRB-	5259
OEC transplantation	5259
A	5280
The quantitative analysis	5284
B	5324
the significant difference of Relative OD Value between hemisected group and OECs transplantation group -LRB- * P < 0.05 -RRB-	5338
the significant difference	5338
Relative OD Value between hemisected group and OECs transplantation group -LRB- * P < 0.05 -RRB-	5368
Relative OD Value	5368
hemisected group and OECs transplantation group -LRB- * P < 0.05 -RRB-	5394
hemisected group and OECs transplantation group	5394
P <	5444
P	5444
<	5446
0.05	5448
Figure 6 Changes of ERK and p-ERK in OEC treated rats .	5456
Figure 6 Changes	5456
ERK and p-ERK	5476
OEC	5493
rats	5505
the sham group and the injury group	5524
the sham group	5524
the injury group	5543
OECs graft	5561
a significant increase on the p-ERK expression	5584
a significant increase	5584
the p-ERK expression	5610
the 14th day and the 21st day	5639
the 14th day	5639
the 21st day	5656
there	5675
no differences on the ERK expression among three groups -LRB- A -RRB-	5686
no differences	5686
the ERK expression among three groups -LRB- A -RRB-	5704
the ERK expression	5704
three groups -LRB- A -RRB-	5729
three groups	5729
A	5743
The quantitative analyses for ERK and p-ERK on the 14th day and the 21st day	5747
The quantitative analyses	5747
ERK and p-ERK on the 14th day and the 21st day	5777
ERK and p-ERK	5777
the 14th day and the 21st day	5794
the 14th day	5794
the 21st day	5811
B-C	5839
The images	5844
the p-ERK	5870
expression increase	5880
P <	5916
P	5916
<	5918
0.05	5920
the 14th day -LRB- B -RRB- and the 21st day -LRB- C -RRB-	5929
the 14th day	5929
B	5943
the 21st day	5950
C	5964
Identification of OECs in vitro After 24 h of culturing , the adherent cells	5969
Identification	5969
OECs in vitro After 24 h of culturing , the adherent cells	5987
OECs	5987
24 h of culturing , the adherent cells	6007
24 h	6007
culturing , the adherent cells	6015
culturing	6015
the adherent cells	6026
shape and uniform distribution	6061
shape	6061
uniform distribution	6071
3 days of culture	6099
3 days	6099
culture	6109
the cell bodies	6118
most of them	6163
most	6163
them	6171
triangles	6183
two or three processes	6198
5 -- 7 days of culture	6228
5	6228
7 days of culture	6230
7 days	6230
culture	6240
the characteristics of OECs in vitro	6249
the characteristics	6249
OECs in vitro	6272
OECs	6272
the cell processes	6302
they	6351
a network -LRB- Figure 1A -RRB-	6381
a network	6381
Figure 1A	6392
Enzyme immunochemical staining of the cultured cells	6404
Enzyme immunochemical staining	6404
the cultured cells	6438
the	6438
cells	6451
neurotrophin p75 surface receptor	6475
OECs	6524
The purity of OECs	6530
The purity	6530
OECs	6544
95 %	6564
These cells	6569
a DAB reaction product	6595
these cells -LRB- Figure 1B -RRB-	6633
these cells	6633
Figure 1B	6646
addition	6661
OECs	6671
the GFP transgenic mice could emit green fluorescence -LRB- Figure 1C -RRB-	6689
the GFP	6689
transgenic mice	6697
green fluorescence -LRB- Figure 1C -RRB-	6724
green fluorescence	6724
Figure 1C	6744
red fluorescent staining under incubation by p75 antibody	6765
red fluorescent staining	6765
incubation by p75 antibody	6796
incubation	6796
p75 antibody	6810
we	6824
the cultured cells as OECs in vitro -LRB- Figure 1D -RRB-	6843
the cultured cells as OECs in vitro	6843
the	6843
cells as OECs	6856
cells	6856
OECs	6865
Figure 1D	6880
Evaluation on Nociceptive tests	6892
Evaluation	6892
Nociceptive tests	6906
sham-operated rats	6927
the paw withdrawal latency -LRB- PWL -RRB- and paw withdrawal thresholds -LRB- PWT -RRB-	6947
the paw withdrawal latency -LRB- PWL -RRB-	6947
the paw withdrawal latency	6947
PWL	6975
paw withdrawal thresholds -LRB- PWT -RRB-	6984
paw withdrawal thresholds	6984
PWT	7011
Thermal stimuli	7042
the nociceptive evaluation of thermal stimuli	7061
the nociceptive evaluation	7061
thermal stimuli	7091
these asterisks	7108
the left PWL of the OEC transplantation group -LRB- 4.41 ± 2.38 s -RRB-	7138
the left PWL	7138
the OEC transplantation group -LRB- 4.41 ± 2.38 s -RRB-	7154
the OEC transplantation group	7154
4.41 ± 2.38 s	7185
4.41 ± 2.38	7185
4.41	7185
2.38	7192
s	7197
those of hSCI group -LRB- 7.42 ± 4.20 s -RRB- -LRB- * P < 0.05 -RRB- and the sham group -LRB- 9.06 ± 1.28 s -RRB- -LRB- *** P < 0.001 -RRB-	7229
those of hSCI group -LRB- 7.42 ± 4.20 s -RRB- -LRB- * P < 0.05 -RRB-	7229
those	7229
hSCI group -LRB- 7.42 ± 4.20 s -RRB- -LRB- * P < 0.05 -RRB-	7238
hSCI group -LRB- 7.42 ± 4.20 s -RRB-	7238
hSCI group	7238
7.42 ± 4.20 s	7250
7.42	7250
4.20 s	7257
P <	7266
P	7266
<	7268
0.05	7270
the sham group -LRB- 9.06 ± 1.28 s -RRB- -LRB- *** P < 0.001 -RRB-	7280
the sham group -LRB- 9.06 ± 1.28 s -RRB-	7280
the sham group	7280
9.06 ± 1.28 s	7296
9.06	7296
1.28 s	7303
*** P < 0.001	7312
*** P	7312
< 0.001	7317
<	7317
0.001	7319
There	7327
no significant difference in left PWL between the sham group and the hSCI group	7337
no significant difference	7337
left PWL between the sham group and the hSCI group	7366
left PWL	7366
the sham group and the hSCI group	7383
the sham group	7383
the hSCI group	7402
The quantitative analysis	7418
Figure 2A	7456
Mechanical stimuli	7467
the pressure stimuli expressed by grams to the injury-side hind paws of rats in each group	7495
the pressure stimuli	7495
grams	7529
the injury-side hind paws of rats in each group	7538
the injury-side hind paws	7538
rats in each group	7567
rats	7567
each group	7575
we	7587
the PWTs of sham group -LRB- 192.67 ± 39.25 g -RRB-	7601
the PWTs	7601
sham group -LRB- 192.67 ± 39.25 g -RRB-	7613
sham group	7613
192.67 ± 39.25 g	7625
192.67 ± 39.25	7625
192.67	7625
39.25	7634
g	7640
those of the hSCI group -LRB- 113.33 ± 49.24 g -RRB- -LRB- *** P < 0.001 -RRB- , and the OEC treatment group -LRB- 93.33 ± 74.63 g -RRB-	7674
those of the hSCI group -LRB- 113.33 ± 49.24 g -RRB- -LRB- *** P < 0.001 -RRB-	7674
those	7674
the hSCI group -LRB- 113.33 ± 49.24 g -RRB- -LRB- *** P < 0.001 -RRB-	7683
the hSCI group -LRB- 113.33 ± 49.24 g -RRB-	7683
the hSCI group	7683
113.33 ± 49.24 g	7699
113.33	7699
49.24 g	7708
*** P < 0.001	7718
*** P	7718
< 0.001	7723
<	7723
0.001	7725
the OEC treatment group -LRB- 93.33 ± 74.63 g -RRB-	7737
the OEC treatment group	7737
93.33 ± 74.63 g	7762
93.33	7762
74.63 g	7770
the lowest level -LRB- *** P < 0.001 -RRB-	7789
the lowest level	7789
*** P < 0.001	7807
*** P	7807
< 0.001	7812
<	7812
0.001	7814
The quantitative analysis	7822
Figure 2B	7860
Survival and migrating of OECs in vivo To confirm the survival of OECs with spinal cord injury , GFP -LRB- green fluorescent protein -RRB- - positive OECs were observed .	7871
Survival and migrating of OECs in vivo To confirm the survival of OECs with spinal cord injury , GFP -LRB- green fluorescent protein -RRB-	7871
Survival and migrating	7871
OECs in vivo To confirm the survival of OECs with spinal cord injury , GFP -LRB- green fluorescent protein -RRB-	7897
OECs	7897
vivo	7905
the survival of OECs	7921
the survival	7921
OECs	7937
spinal cord injury , GFP -LRB- green fluorescent protein -RRB-	7947
spinal cord injury	7947
GFP -LRB- green fluorescent protein -RRB-	7967
GFP	7967
green fluorescent protein	7972
positive OECs	7999
Figure 3A	8040
GFP-labeled OECs with fluorescence	8057
GFP-labeled OECs	8057
fluorescence	8079
the spinal cord	8105
The results	8122
the implanted OECs	8149
surviving and migration in the spinal cord	8184
surviving and migration	8184
the spinal cord	8211
one	8232
month	8236
injury	8248
the situation of the hSCI group without cells transplantation -LRB- Figure 3B -RRB-	8270
the situation	8270
the hSCI group without cells transplantation -LRB- Figure 3B -RRB-	8287
the hSCI group	8287
cells transplantation -LRB- Figure 3B -RRB-	8310
cells transplantation	8310
Figure 3B	8333
BDNF co-expression	8345
OECs and host neurons	8377
OECs	8377
host neurons	8386
order	8402
the change of BDNF-positive cells	8421
the change	8421
BDNF-positive cells	8435
we	8456
the immunofluorescent staining	8469
BDNF antibodies	8509
The secondary antibodies	8526
the fluorescent marker Cy-3 , which emits red fluorescence to be observed by fluorescent microscope	8570
the fluorescent marker Cy-3	8570
red fluorescence to be observed by fluorescent microscope	8611
fluorescent microscope	8646
the sham group -LRB- Figure 3D -RRB- and the hSCI group -LRB- Figure 3E -RRB-	8684
the sham group	8684
Figure 3D	8700
the hSCI group	8715
Figure 3E	8731
the number of BDNF-positive cells	8743
the number	8743
BDNF-positive cells	8757
the OECs transplantation group -LRB- Figure 3F -RRB-	8794
the OECs transplantation group	8794
Figure 3F	8826
The quantitative analysis on the comparison of the numbers of BDNF-positive cells	8838
The quantitative analysis	8838
the comparison of the numbers of BDNF-positive cells	8867
the comparison	8867
the numbers of BDNF-positive cells	8885
the numbers	8885
BDNF-positive cells	8900
Figure 3G , which shows significant difference between the OECs transplantation group and the hSCI group -LRB- * P < 0.05 -RRB-	8932
Figure 3G	8932
significant difference between the OECs transplantation group and the hSCI group -LRB- * P < 0.05 -RRB-	8955
significant difference between the OECs transplantation group	8955
significant difference	8955
the OECs transplantation group	8986
the hSCI group -LRB- * P < 0.05 -RRB-	9021
the hSCI group	9021
P <	9038
P	9038
<	9040
0.05	9042
The images	9049
BDNF-positive cells	9070
OECs engrafted with GFP fluorescence -LRB- Figure 3F -RRB-	9115
OECs	9115
GFP fluorescence -LRB- Figure 3F -RRB-	9135
GFP fluorescence	9135
Figure 3F	9153
neurons in the superficial layer of dorsal horn	9177
neurons	9177
the superficial layer of dorsal horn	9188
the superficial layer	9188
dorsal horn	9213
the spinal cord injury	9237
BDNF co-expression	9261
OECs and host neurons	9293
the co-localization of BDNF	9327
the co-localization	9327
BDNF	9350
host neurons	9358
OECs	9385
the immunofluorecent double-label staining	9391
neuronal marker	9479
Doublelabel staining	9523
the engrafted OECs	9556
the	9556
OECs	9570
BDNF	9587
transplantation -LRB- Figure 4A-4D -RRB-	9598
transplantation	9598
Figure 4A-4D	9615
BDNFpositive cells	9630
anti-NeuN	9680
This	9691
the cells labeled by BDNF staining	9711
the cells	9711
BDNF staining	9732
neurons in the host spinal cord -LRB- Figure 4E-4H -RRB-	9750
neurons	9750
the host spinal cord -LRB- Figure 4E-4H -RRB-	9761
the host spinal cord	9761
Figure 4E-4H	9783
addition	9801
the neurons labeled by BDNF	9811
the neurons	9811
BDNF	9834
TrkB , the functional receptor of BDNF -LRB- Figure 4I-4L -RRB-	9866
TrkB	9866
the functional receptor of BDNF -LRB- Figure 4I-4L -RRB-	9872
the functional receptor	9872
BDNF -LRB- Figure 4I-4L -RRB-	9899
BDNF	9899
Figure 4I-4L	9905
The mRNA changes of BDNF	9920
The mRNA changes	9920
BDNF	9940
RT-PCR	9948
The mRNA expressions for BDNF	9955
The mRNA expressions	9955
BDNF	9980
the sham group , the hSCI group and the OECs transplantation rats	10002
the sham group	10002
the hSCI group	10018
the OECs transplantation rats	10037
Significant difference between the hSCI group and the OEC transplantation group	10068
Significant difference	10068
the hSCI group and the OEC transplantation group	10099
the hSCI group	10099
the OEC transplantation group	10118
the 21st day -LRB- * P < 0.05 -RRB-	10164
the 21st day	10164
P <	10179
P	10179
<	10181
0.05	10183
other time points	10201
OEC transplantation	10231
the BDNF expression in the spinal cord	10282
the BDNF expression	10282
the spinal cord	10305
injury -LRB- Figure 5A , Figure 5B -RRB-	10327
injury	10327
Figure 5A	10335
Figure 5B	10346
Changes of ERK and p-ERK expressions detected by Western blot ERK activation	10358
Changes	10358
ERK and p-ERK expressions detected by Western blot ERK activation	10369
ERK and p-ERK expressions	10369
Western blot ERK activation	10407
Western blotting	10453
the sham group	10485
there	10501
no changes on the expressions of ERK following SCI Figure 6A	10512
no changes	10512
the expressions of ERK following SCI Figure 6A	10526
the expressions	10526
ERK following SCI Figure 6A	10545
ERK	10545
SCI Figure 6A	10559
the OEC administration	10583
a significant increase on the level of p-ERK in the spinal cord	10618
a significant increase	10618
the level of p-ERK in the spinal cord	10644
the level	10644
p-ERK in the spinal cord	10657
p-ERK	10657
the spinal cord	10666
the 14th day and the 21st day -LRB- * P < 0.05 -RRB- -LRB- Figure 6B-6C -RRB-	10690
the 14th day	10690
the 21st day -LRB- * P < 0.05 -RRB- -LRB- Figure 6B-6C -RRB-	10707
the 21st day -LRB- * P < 0.05 -RRB-	10707
the 21st day	10707
P <	10722
P	10722
<	10724
0.05	10726
Figure 6B-6C	10733
Discussion The results	10749
Discussion	10749
The results	10760
the OECs from olfactory bulb	10782
the OECs	10782
olfactory bulb	10796
hyperalgesia	10822
they	10840
the hemisected spinal cord in rats	10868
the hemisected spinal cord	10868
rats	10898
this phenomenon	10908
the activation of ERK and the increase of BDNF level , indicated by RT-PCR and Western Blot	10953
the activation of ERK	10953
the activation	10953
ERK	10971
the increase of BDNF level , indicated by RT-PCR and Western Blot	10979
the increase	10979
BDNF level	10995
RT-PCR and Western Blot	11020
RT-PCR	11020
Western Blot	11031
cell transplantation	11056
one novel therapeutic strategy for the treatment of SCI	11080
one novel therapeutic strategy	11080
the treatment of SCI	11115
the treatment	11115
SCI	11132
one type of glial cells ensheathed in the olfactory axons	11140
one type	11140
glial cells ensheathed in the olfactory axons	11152
glial cells	11152
the olfactory axons	11178
OECs	11199
the function of promoting the axonal regeneration	11220
the function	11220
the axonal regeneration	11246
Several studies	11271
the optimal role of OECs in the treatment of SCI , which may induce function repair for improving locomotor level -LSB- 8,10-13 -RSB- and promoting axonal regeneration -LSB- 14,15 -RSB- , in the paraplegic -LSB- 10 -RSB- , transected -LSB- 13,14 -RSB- , contused -LSB- 8 -RSB- SCI models and multiple lumbar rhizotomy -LSB- 16 -RSB-	11298
the optimal role	11298
OECs in the treatment of SCI , which may induce function repair for improving locomotor level -LSB- 8,10-13 -RSB- and promoting axonal regeneration -LSB- 14,15 -RSB- , in the paraplegic -LSB- 10 -RSB- , transected -LSB- 13,14 -RSB- , contused -LSB- 8 -RSB- SCI models and multiple lumbar rhizotomy -LSB- 16 -RSB-	11318
OECs	11318
the treatment of SCI , which may induce function repair for improving locomotor level -LSB- 8,10-13 -RSB- and promoting axonal regeneration -LSB- 14,15 -RSB- , in the paraplegic -LSB- 10 -RSB- , transected -LSB- 13,14 -RSB- , contused -LSB- 8 -RSB- SCI models and multiple lumbar rhizotomy -LSB- 16 -RSB-	11326
the treatment	11326
SCI , which may induce function repair for improving locomotor level -LSB- 8,10-13 -RSB- and promoting axonal regeneration -LSB- 14,15 -RSB- , in the paraplegic -LSB- 10 -RSB- , transected -LSB- 13,14 -RSB- , contused -LSB- 8 -RSB- SCI models and multiple lumbar rhizotomy -LSB- 16 -RSB-	11343
SCI	11343
function repair	11365
locomotor level -LSB- 8,10-13 -RSB-	11395
locomotor level	11395
8,10-13 -RSB-	11412
axonal regeneration -LSB- 14,15 -RSB- , in the paraplegic -LSB- 10 -RSB- , transected -LSB- 13,14 -RSB- , contused -LSB- 8 -RSB- SCI models and multiple lumbar rhizotomy -LSB- 16 -RSB-	11435
axonal regeneration -LSB- 14,15 -RSB- , in the paraplegic -LSB- 10 -RSB- , transected -LSB- 13,14 -RSB- , contused -LSB- 8 -RSB- SCI models	11435
axonal regeneration -LSB- 14,15 -RSB- ,	11435
axonal regeneration	11435
14,15 -RSB-	11456
the paraplegic -LSB-	11467
transected -LSB- 13,14 -RSB-	11488
-LSB- 13,14	11499
8 -RSB- SCI models	11518
multiple lumbar rhizotomy -LSB- 16 -RSB-	11536
multiple lumbar rhizotomy	11536
16 -RSB-	11563
the introduction of OECs	11578
the introduction	11578
OECs	11598
the demyelinated axons	11619
the lesions of the animal spinal cord -LSB- 17-19 -RSB-	11645
the lesions	11645
the animal spinal cord -LSB- 17-19 -RSB-	11660
the animal spinal cord	11660
17-19 -RSB-	11684
there	11716
no evidence to reveal how this transplantation affects the sensory function	11725
this transplantation	11751
the sensory function	11780
we	11813
the treatment of OEC transplantation in rat hSCI model	11836
the treatment	11836
OEC transplantation in rat hSCI model	11853
OEC transplantation	11853
rat hSCI model	11876
the regulation of sensory function	11902
the regulation	11902
sensory function	11920
the motor function	11940
The innocuous mechanical and thermal stimuli	11960
the OECs treatment group	12022
lower PWL than the untreated group	12051
lower PWL	12051
the untreated group	12066
This result	12087
the OEC transplantation into spinal cord injured rats	12113
the OEC transplantation	12113
spinal cord injured rats	12142
spinal cord	12142
rats	12162
obvious hyperalgesic responses	12178
this reason	12214
the analgesic approach	12227
we	12275
the OEC transplantation therapy	12287
the underlying mechanism of the allodynia following OEC implantation	12335
the underlying mechanism	12335
the allodynia following OEC implantation	12363
the allodynia	12363
OEC implantation	12387
we	12405
the expressions of BDNF and ERK	12419
the expressions	12419
BDNF and ERK	12438
BDNF expression in injured spinal cord	12466
BDNF expression	12466
injured spinal cord	12485
OEC-transplanted rats on 21st day	12530
OEC-transplanted rats	12530
21st day	12555
BDNF	12568
neurons of the superficial layer in the dorsal horn	12588
neurons	12588
the superficial layer in the dorsal horn	12599
the superficial layer	12599
the dorsal horn	12624
It	12641
the productions of growth factors -LRB- NGF , BDNF , and GDNF -RRB- and the expressions of corresponding receptors	12658
the productions	12658
growth factors -LRB- NGF , BDNF , and GDNF -RRB- and the expressions of corresponding receptors	12677
growth factors -LRB- NGF , BDNF , and GDNF -RRB-	12677
growth factors	12677
NGF , BDNF , and GDNF	12693
NGF	12693
BDNF	12698
GDNF	12708
the expressions of corresponding receptors	12718
the expressions	12718
corresponding receptors	12737
axonal regeneration following OEC transplantation -LSB- 5 -RSB-	12779
axonal regeneration	12779
OEC transplantation -LSB- 5 -RSB-	12809
OEC transplantation	12809
5 -RSB-	12830
BDNF as one type of the neurotrophin family of growth factors	12834
BDNF	12834
one type of the neurotrophin family of growth factors	12842
one type	12842
the neurotrophin family of growth factors	12854
the neurotrophin family	12854
growth factors	12881
the survival of the existing neurons	12917
the survival	12917
the existing neurons	12933
the growth and differentiation of new neurons and synapses	12966
the growth and differentiation	12966
new neurons and synapses	13000
20,21 -RSB-	13026
the pain in sciatic nerve separation model -LSB- 22 -RSB- and ligation model	13051
the pain	13051
sciatic nerve separation model -LSB- 22 -RSB- and ligation model	13063
sciatic nerve separation model	13063
22 -RSB-	13095
ligation model	13103
23 -RSB-	13119
our experiments	13127
immunofluorescent staining	13144
the expression of BDNF	13196
the expression	13196
BDNF	13214
the injured segment , and the red fluorescence which symbolized `` BDNF positive '' was found in the superficial layer of dorsal horn	13222
the injured segment	13222
the red fluorescence which symbolized `` BDNF positive '' was found in the superficial layer of dorsal horn	13247
the red fluorescence	13247
BDNF positive	13286
the superficial layer of dorsal horn	13314
the superficial layer	13314
dorsal horn	13339
the upregulation of BDNF expression	13368
the upregulation	13368
BDNF expression	13388
These results	13424
OEC transplantation	13453
BDNF expression	13488
sensory neurons of the dorsal horn , which may contribute to the observed phenomena like hyperalgesia	13507
sensory neurons	13507
the dorsal horn , which may contribute to the observed phenomena like hyperalgesia	13526
the dorsal horn	13526
the observed phenomena like hyperalgesia	13567
the observed phenomena	13567
hyperalgesia	13595
we	13627
the p-ERK -LRB- phosphorylation of extracellular signal-regulated kinase -RRB- level was increased in the injured spinal cord after OEC transplantation	13641
the p-ERK	13641
phosphorylation of extracellular signal-regulated kinase	13652
phosphorylation	13652
extracellular signal-regulated kinase	13671
level	13710
the injured spinal cord	13733
OEC transplantation	13763
The potential correlation of the activation of ERK following spinal neuron injury with the pain hypersensitivity and central sensitization	13784
The potential correlation	13784
the activation of ERK following spinal neuron injury with the pain hypersensitivity and central sensitization	13813
the activation	13813
ERK following spinal neuron injury with the pain hypersensitivity and central sensitization	13831
ERK	13831
spinal neuron injury with the pain hypersensitivity and central sensitization	13845
spinal neuron injury	13845
the pain hypersensitivity and central sensitization	13871
the pain hypersensitivity	13871
central sensitization	13901
24,25 -RSB-	13944
a minute after a noxious stimulus	13959
a minute	13959
a noxious stimulus	13974
many p - ERK-positive neurons were observed , predominantly in laminas I and II of the ipsilateral dorsal horn -LSB- 26 -RSB- , and the phosphorylation of ERK occurring in the nociceptive neurons	13994
many p	13994
ERK-positive neurons were observed	14002
ERK-positive neurons	14002
laminas I and II of the ipsilateral dorsal horn -LSB- 26 -RSB- , and the phosphorylation of ERK occurring in the nociceptive neurons	14055
laminas I and II	14055
the ipsilateral dorsal horn -LSB- 26 -RSB- , and the phosphorylation of ERK	14075
the ipsilateral dorsal horn	14075
26 -RSB- , and the phosphorylation of ERK	14104
26 -RSB-	14104
the phosphorylation of ERK	14113
the phosphorylation	14113
ERK	14136
the nociceptive neurons	14153
persistent inflammatory and neuropathic pains	14195
27 -RSB-	14242
present study	14250
we	14265
the activation of ERK	14277
the activation	14277
ERK	14295
OEC transplantation , which may be related to hyperalgesia	14309
OEC transplantation	14309
hyperalgesia	14354
this observation	14371
several events including behavior and molecule	14389
several events	14389
behavior and molecule	14414
different time points	14453
the ERK phosphorylation	14488
a reason for the increase of BDNF -LSB- 28 -RSB-	14519
a reason	14519
the increase of BDNF -LSB- 28 -RSB-	14532
the increase	14532
BDNF -LSB- 28 -RSB-	14548
BDNF	14548
28 -RSB-	14554
the increase of ERK phosphorylation on the 14th day	14570
the increase	14570
ERK phosphorylation on the 14th day	14586
ERK phosphorylation	14586
the 14th day	14609
the increase of BDNF level	14633
the increase	14633
BDNF level	14649
the 21st day	14663
the behavioral changes	14680
the cellular and molecular changes	14733
hyperalgesia	14769
1	14798
month	14800
the phosphorylation of ERK	14817
the phosphorylation	14817
ERK	14840
the upregulation of BDNF	14855
the upregulation	14855
BDNF	14875
rise	14902
the behavioral hyperalgesia	14910
We	14939
BDNF	14958
OECs	14985
host neurons	14997
the neurons with BDNF staining	15014
the neurons	15014
BDNF staining	15031
TrkB	15060
probably the BDNF released from OECs	15081
probably the BDNF	15081
OECs	15113
neurons	15141
TrkB receptor	15152
These	15167
some linkage	15189
BDNF	15205
the consequent hyperalgesia between transplanted OECs and host neurons	15214
the consequent hyperalgesia	15214
transplanted OECs and host neurons	15250
summary	15289
these findings	15298
novel insight	15325
the hyperalgesia responses following OEC transplantation	15344
the hyperalgesia responses	15344
OEC transplantation	15381
OEC transplantation	15411
the treatment of SCI	15435
the treatment	15435
SCI	15452
it	15457
the inhibition of ERK phosphorylation and BDNF blockage	15482
the inhibition	15482
ERK phosphorylation and BDNF blockage	15500
ERK phosphorylation	15500
BDNF blockage	15524
the nociceptive behaviors	15549
Methods Animal and grouping Adult Sprague -- Dawley rats weighing 180 -- 220 g , obtained from the Animal Center of the Sichuan University , were used in this experiment .	15577
Methods Animal and grouping Adult Sprague -- Dawley rats weighing 180	15577
Methods	15577
Animal	15585
Adult Sprague -- Dawley rats weighing 180	15605
Adult Sprague	15605
Dawley rats	15619
180	15640
220 g , obtained from the Animal Center of the Sichuan University ,	15644
220 g	15644
the Animal Center of the Sichuan University	15665
the Animal Center	15665
the Sichuan University	15686
this experiment	15723
The animals	15740
three groups randomly -LRB- Table 1 -RRB- : Group A rats were underwent hemisected spinal cord injury at the eighth thoracic -LRB- T10 -RRB- cord level , Group B rats were received OECs transplantation after injury , Group C rats were as the sham group -LRB- rats were underwent neither SCI nor transplant injections -RRB-	15770
three groups randomly	15770
three groups	15770
Table 1 -RRB- : Group A rats were underwent hemisected spinal cord injury at the eighth thoracic -LRB- T10 -RRB- cord level , Group B rats were received OECs transplantation after injury , Group C rats were as the sham group -LRB- rats were underwent neither SCI nor transplant injections	15793
Table	15793
Group A rats	15803
Group A	15803
rats	15811
hemisected spinal cord injury at the eighth thoracic -LRB- T10 -RRB-	15831
hemisected spinal cord injury	15831
the eighth thoracic -LRB- T10 -RRB-	15864
the eighth thoracic	15864
T10	15885
cord level	15890
Group B rats	15902
OECs transplantation	15929
injury	15956
Group C rats	15964
the sham group -LRB- rats were underwent neither SCI nor transplant injections	15985
the sham group	15985
rats	16001
neither SCI nor transplant injections	16021
SCI	16029
transplant injections	16037
Ethics statement The animal study proposal	16061
Ethics statement	16061
The animal study proposal	16078
the Animal Care & Welfare Committee of West China Hospital , Sichuan University with the approval number : 201	16128
the Animal Care & Welfare Committee	16128
West China Hospital , Sichuan University with the approval number : 201	16167
West China Hospital	16167
Sichuan University with the approval number : 201	16188
Sichuan University with the approval number	16188
Sichuan University	16188
the approval number	16212
201	16233
All the experiment	16238
the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health	16269
the Guide	16269
the Care and Use	16283
Laboratory Animals published by the US National Institutes of Health	16303
Laboratory Animals	16303
the US National Institutes of Health	16335
the US National Institutes	16335
Health	16365
Isolation , cell preparation and identification of OECs in vitro The GFP -LRB- green fluorescent protein -RRB- transgenic mice -LSB- 29 -RSB-	16373
Isolation	16373
cell preparation and identification of OECs in vitro The GFP -LRB- green fluorescent protein -RRB- transgenic mice -LSB- 29	16384
cell preparation and identification	16384
OECs in vitro The GFP -LRB- green fluorescent protein -RRB- transgenic mice -LSB- 29	16423
OECs	16423
The GFP -LRB- green fluorescent protein -RRB- transgenic mice -LSB- 29	16437
The GFP -LRB- green fluorescent protein -RRB- transgenic mice	16437
The GFP	16437
green fluorescent protein	16446
transgenic mice	16473
29	16490
incubation	16513
the 75 % alcohol for 1 -- 2 min	16527
the 75 % alcohol for 1	16527
the 75 % alcohol	16527
1	16547
2 min	16549
decapitation	16579
the head	16611
the culture medium -LRB- DMEM with Ham 's F12 - 1:1 , Gibco -RRB-	16635
the culture medium	16635
DMEM with Ham 's F12 - 1:1 , Gibco	16655
DMEM	16655
Ham 's F12 - 1:1 , Gibco	16665
Ham 's F12	16665
Ham 's	16665
1:1 , Gibco	16677
1:1	16677
Gibco	16682
the microscope	16699
the olfactory bulb	16715
the cold 10 % FBS medium	16774
two times	16813
DMED medium	16826
the tissue block	16839
sedimentation	16883
the supernatant	16917
new DMEM medium	16934
micropipette	16970
the tissue block	16984
cell suspension	17020
the cell pellets of OECs	17042
the cell pellets	17042
OECs	17062
a poly-L lysine-coated culture flask at a concentration of 1 × 106/ml	17082
a poly-L lysine-coated culture flask	17082
a concentration of 1 × 106/ml	17122
a concentration	17122
1 × 106/ml	17141
The culture	17153
37 °C with 5 % carbon dioxide	17183
37 °C	17183
5 % carbon dioxide	17193
an atmosphere of 95 % humidity	17214
an atmosphere	17214
95 % humidity	17231
first 12-h incubation	17251
the culture media	17274
another flask	17314
this process	17332
the fibroblasts	17377
The culture media containing purified OECs	17394
The culture media	17394
purified OECs	17423
flask for 7 days	17454
flask	17454
7 days	17464
then	17476
the numbers of cells	17506
the numbers	17506
cells	17521
the 3rd passage	17532
the character of cultured OECs	17561
the character	17561
OECs	17587
the low-affinity neurotrophin receptor p75NGFR -LRB- 1:400 , Santa Cruz Biotechnology -RRB-	17593
the low-affinity neurotrophin receptor p75NGFR	17593
1:400 , Santa Cruz Biotechnology	17641
1:400	17641
Santa Cruz Biotechnology	17648
OECs	17693
4 % paraformaldehyde in 0.1 M phosphatebuffered saline -LRB- PBS -RRB- for 30 min	17714
4 % paraformaldehyde	17714
0.1 M phosphatebuffered saline -LRB- PBS -RRB- for 30 min	17737
0.1 M	17737
saline -LRB- PBS -RRB- for 30 min	17761
saline -LRB- PBS -RRB-	17761
saline	17761
PBS	17769
30 min	17778
immunohistochemistry	17790
the cells	17812
three times	17834
0.01 M PBS	17849
3 % hydrogen peroxide	17887
room temperature for 20 min	17911
room temperature	17911
20 min	17932
the action of various endogenous peroxidase	17957
the action	17957
various endogenous peroxidase	17971
30 min immersion in PBS -LRB- containing 0.3 % Triton X-100 and 5 % normal goat serum -RRB- at 37 °C	18008
30 min immersion in PBS -LRB- containing 0.3 % Triton X-100 and 5 % normal goat serum -RRB-	18008
30 min immersion in PBS	18008
30 min immersion	18008
PBS	18028
0.3 % Triton X-100 and 5 % normal goat serum	18044
0.3 % Triton X-100	18044
5 % normal goat serum	18066
37 °C	18091
they	18097
an incubation with anti-rabbit p75 -LRB- 1:400 , Santa Cruz Biotechnology -RRB-	18121
an incubation	18121
anti-rabbit p75 -LRB- 1:400 , Santa Cruz Biotechnology -RRB-	18140
anti-rabbit p75	18140
1:400 , Santa Cruz Biotechnology	18157
1:400	18157
Santa Cruz Biotechnology	18164
4 °C overnight	18193
4 °C	18193
three times	18222
goat-anti-rabbit IgG	18235
incubation for 2 h	18269
incubation	18269
2 h	18284
37 °C	18291
they	18312
DAB in hydrogen peroxide	18335
DAB	18335
hydrogen peroxide	18342
staining for 5 min	18371
staining	18371
5 min	18384
the cells	18391
the digital images of the cells	18433
the digital images	18433
the cells	18455
the LEICA automatic photo micrographic system	18501
the purity of OECs	18561
the purity	18561
OECs	18575
the percentage of P75 positive cells	18581
the percentage	18581
P75 positive cells	18599
Immunofluorescent staining in vitro For immunofluorescent staining , the OECs were washed in PBS for 10 min ,	18631
Immunofluorescent staining	18631
immunofluorescent staining	18671
the OECs	18699
PBS for 10 min	18723
PBS	18723
10 min	18731
5 % normal goat serum -LRB- NGS , Sigma -RRB- , and 0.3 % Triton X-100 in PBS	18750
5 % normal goat serum -LRB- NGS , Sigma -RRB-	18750
5 %	18750
normal goat serum -LRB- NGS , Sigma -RRB-	18753
normal goat serum	18753
NGS	18772
Sigma	18777
0.3 % Triton X-100 in PBS	18789
0.3 % Triton X-100	18789
PBS	18810
1 hour at room temperature	18818
1 hour	18818
room temperature	18828
they	18857
rabbit anti-p75 -LRB- anti-rabbit , 1:400 , Santa Cruz Biotechnology -RRB- in OECs for 2 h	18882
rabbit anti-p75 -LRB- anti-rabbit , 1:400 , Santa Cruz Biotechnology -RRB-	18882
rabbit anti-p75	18882
anti-rabbit , 1:400 , Santa Cruz Biotechnology	18899
anti-rabbit	18899
1:400	18912
Santa Cruz Biotechnology	18919
OECs for 2 h	18948
OECs	18948
2 h	18957
37 °C	18964
4 °C	19006
three times and the incubation	19025
three times	19025
the incubation	19041
fluorescent secondary antibody IgG -LRB- Goat anti-rabbit CY3 : red -RRB- for 2 h at 37 °C	19061
fluorescent secondary antibody IgG -LRB- Goat anti-rabbit CY3 : red -RRB-	19061
fluorescent secondary antibody IgG	19061
Goat anti-rabbit CY3 : red	19097
Goat anti-rabbit CY3	19097
red	19119
2 h at 37 °C	19128
2 h	19128
37 °C	19135
they	19141
fluorescent microscope	19166
The control cells	19190
PBS	19226
the primary antibody	19241
Hemisected spinal cord injury model and administration of ciclosporin A After anesthetization by intraperitoneal injection of 3.6 % chloral hydrate , rats were placed prone on an operating table covered by a warming blanket to maintain the body temperature at 37.0 ± 0.50 °C , and then	19263
Hemisected spinal cord injury	19263
model and administration	19293
ciclosporin A	19321
anesthetization by intraperitoneal injection of 3.6 % chloral hydrate	19341
anesthetization	19341
intraperitoneal injection of 3.6 % chloral hydrate	19360
intraperitoneal injection	19360
3.6 % chloral hydrate	19389
rats	19411
an operating table covered by a warming blanket to maintain the body temperature at 37.0 ± 0.50 °C , and then	19437
an operating table	19437
a warming blanket	19467
the body temperature	19497
37.0 ± 0.50 °C , and then	19521
37.0 ± 0.50 °C	19521
37.0 ±	19521
0.50 °C	19528
then	19540
the laminectomy	19560
the T10 level	19579
The spinal cord	19594
microscissors under an operating microscope	19630
microscissors	19630
an operating microscope	19650
The microscissors	19675
the spinal cord	19712
the tip touching the midline until the left side of the cord was completely divided	19733
the tip	19733
the midline	19750
the left side of the cord	19768
the left side	19768
the cord	19785
the immunological rejection	19829
the immunosuppressive agent , known as ciclosporin A -LRB- 5 mg/ml -RRB- ,	19858
the immunosuppressive agent	19858
ciclosporin A -LRB- 5 mg/ml -RRB-	19896
ciclosporin A	19896
5 mg/ml	19911
intraperitoneally 2 days	19938
cell transplantation	19970
The administration	19992
a day	20027
the animals	20040
Cell transplantation	20069
cord hemisection	20096
rats	20114
OECs treatment -LRB- n = 5 -RRB- , or normal saline administration -LRB- SCI Group , n = 5 -RRB-	20142
OECs treatment -LRB- n = 5 -RRB-	20142
OECs treatment	20142
n	20158
5	20162
normal saline administration -LRB- SCI Group , n = 5 -RRB-	20169
normal saline administration	20169
SCI Group , n = 5	20199
SCI Group	20199
n = 5	20210
n	20210
5	20214
other five rats	20222
neither SCI nor transplant injections -LRB- Sham Group , n = 5 -RRB-	20253
SCI	20261
transplant injections -LRB- Sham Group , n = 5 -RRB-	20269
transplant injections	20269
Sham Group , n = 5	20292
Sham Group	20292
n = 5	20304
n	20304
5	20308
microscopic visualization	20318
5 μl OECs at a concentration of 3 × 106/ml	20345
5 μl OECs	20345
a concentration of 3 × 106/ml	20358
a concentration	20358
3 × 106/ml	20377
the spinal cord around the injury site	20407
the spinal cord	20407
the injury site	20430
The sham group rats	20447
laminectomies	20482
SCI or transplant injections	20509
injection	20545
the superficial back muscles and the skin	20556
the superficial back muscles	20556
the skin	20589
the midline	20617
All the operated rats	20630
the administration of penicillin for 3 days	20699
the administration	20699
penicillin for 3 days	20721
penicillin	20721
3 days	20736
Behavior test	20744
the nociceptive sensory assessment One month after cells injection , sensation of each group on the mechanical and thermal stimulation	20759
the nociceptive sensory assessment	20759
One month	20794
cells injection , sensation of each group on the mechanical and thermal stimulation	20810
cells injection	20810
sensation of each group on the mechanical and thermal stimulation	20827
sensation	20827
each group on the mechanical and thermal stimulation	20840
each group	20840
the mechanical and thermal stimulation	20854
Hind paw sensitivity to innocuous mechanical stimulation	20907
Hind paw sensitivity	20907
innocuous mechanical stimulation	20931
ANALGESY METER -LRB- UGO BASILE , Italy , 37215 -RRB-	20981
ANALGESY METER	20981
UGO BASILE	20997
Italy	21009
37215	21016
the previous description of Randall and Selitto	21037
the previous description	21037
Randall and Selitto	21065
30 -RSB- , the nociceptive thresholds -LRB- also called paw withdrawal threshold , PWT -RRB- , expressed in grams ,	21086
30 -RSB- , the nociceptive thresholds -LRB- also called paw withdrawal threshold , PWT -RRB-	21086
30 -RSB-	21086
the nociceptive thresholds	21091
paw withdrawal threshold , PWT	21131
paw withdrawal threshold	21131
PWT	21157
grams	21176
an increasing pressure	21209
the hind paw	21235
withdrawal	21254
The cut-off point	21266
500 g	21295
the damage	21316
Thermal hyperalgesia	21328
the Plantar Analgesia Meter -LRB- UGO BASILE , Italy , 7370 -RRB-	21365
the Plantar Analgesia Meter	21365
UGO BASILE	21394
Italy	21406
7370	21413
the method described by Hargreaves et al. -LSB- 31 -RSB-	21432
the method	21432
Hargreaves et al. -LSB- 31 -RSB-	21456
Hargreaves et al. -LSB-	21456
31 -RSB-	21475
the rats	21489
transparent plastic enclosures on a glass plate , then acclimatized to test environment for 1 hour	21513
transparent plastic enclosures	21513
a glass plate	21547
environment	21588
1 hour	21604
A fixed intensity -LRB- intensity 80 -RRB- and movable radiant heat source	21612
A fixed intensity -LRB- intensity 80 -RRB-	21612
A fixed intensity	21612
intensity 80	21631
movable radiant heat source	21649
the plate	21699
the plantar surface of each hind paw	21726
the plantar surface	21726
each hind paw	21749
The nociceptive endpoint	21764
obvious withdrawal of the hind paws	21793
obvious withdrawal	21793
the hind paws	21815
the paw withdrawal latency -LRB- PWL -RRB-	21833
the paw withdrawal latency	21833
PWL	21861
An automatic 20 s cutoff	21880
20 s	21893
tissue damage	21925
observation of OECs	21961
observation	21961
OECs	21976
vivo	21984
measurement of sensory function	21995
measurement	21995
sensory function	22010
all rats for immunohistochemistry	22028
all rats	22028
immunohistochemistry	22041
the spinal cords	22082
Spinal cords	22115
microtome -LRB- Leica , Germany -RRB-	22152
microtome	22152
Leica	22163
Germany	22170
20 μm thickness sections	22184
the survival of OECs in host spinal cord	22220
the survival	22220
OECs in host spinal cord	22236
OECs	22236
host spinal cord	22244
the OECs derived from GFP transgenic mice around the lesion site in the spinal cord	22262
the OECs	22262
GFP transgenic mice	22284
the lesion site in the spinal cord	22311
the lesion site	22311
the spinal cord	22330
immunofluorescent microscope	22362
The samples for RT-PCR	22392
The samples	22392
RT-PCR	22408
different time point on the 1st , 3rd , 14th , 21st , 28th day after the operation or OECs administration	22435
different time point	22435
the 1st , 3rd , 14th , 21st , 28th day after the operation or OECs administration	22459
the 1st , 3rd , 14th , 21st , 28th day	22459
the operation or OECs administration	22500
the spinal cords for Western Blot	22544
the spinal cords	22544
Western Blot	22565
the time point	22598
the 14th day and 21st day	22616
the 14th day	22616
21st day	22633
Immunofluorescent observation and double labeling	22643
vivo	22696
the survival of OECs in the spinal cord	22711
the survival	22711
OECs in the spinal cord	22727
OECs	22727
the spinal cord	22735
the spinal cords	22752
20 μm	22785
fluorescent microscope	22817
transplanted OECs	22866
BDNF	22898
the host neurons in the spinal	22908
the host neurons	22908
the spinal	22928
BDNF and its functional receptor TrkB	22953
BDNF	22953
its functional receptor TrkB	22962
we	22992
immunofluorescent staining	23005
sections	23042
3 % goat serum in TBS , then incubated overnight with anti-TrkB -LRB- mouse , 1:400 , MILLIPORE -RRB- , anti-NeuN -LRB- mouse , 1:500 , MILLPORE -RRB- , or anti-BDNF -LRB- rabbit , Chemicon , 1:500 -RRB- at 4 °C	23069
3 % goat serum	23069
TBS	23086
overnight	23106
anti-TrkB -LRB- mouse , 1:400 , MILLIPORE -RRB- , anti-NeuN -LRB- mouse , 1:500 , MILLPORE -RRB- , or anti-BDNF -LRB- rabbit , Chemicon , 1:500 -RRB-	23121
anti-TrkB -LRB- mouse , 1:400 , MILLIPORE -RRB-	23121
anti-TrkB	23121
mouse	23132
1:400	23139
MILLIPORE	23146
anti-NeuN -LRB- mouse , 1:500 , MILLPORE -RRB-	23158
anti-NeuN	23158
mouse	23169
1:500	23176
MILLPORE	23183
anti-BDNF -LRB- rabbit , Chemicon , 1:500 -RRB-	23197
anti-BDNF	23197
rabbit	23208
Chemicon	23216
1:500	23226
4 °C	23236
three times	23255
secondary antibodies conjugated to the fluorescent markers -LRB- anti-rabbit Cy-3 , red light , 1:100 ; anti-mouse 488 : green -RRB-	23268
secondary antibodies	23268
the fluorescent markers -LRB- anti-rabbit Cy-3 , red light , 1:100 ; anti-mouse 488 : green -RRB-	23303
the fluorescent markers	23303
anti-rabbit Cy-3 , red light	23328
anti-rabbit Cy-3	23328
red light	23346
1:100 ; anti-mouse 488 : green	23357
1:100	23357
anti-mouse 488 : green	23364
anti-mouse 488	23364
green	23380
24 h incubation at 4 °C	23401
24 h incubation	23401
4 °C	23420
the sections	23433
fluorescent microscope	23466
three times	23503
The control sections	23516
PBS	23562
there	23571
no positive staining	23580
RT-PCR The tissues from the injury segments of OECS group ,	23602
RT-PCR	23602
The tissues from the injury segments	23609
The tissues	23609
the injury segments	23626
OECS group	23649
group , and sham group were collected and homogenized , respectively -LRB- the 1st , 3rd , 14th , 21st , 28th day -RRB-	23670
group	23670
sham group were collected and homogenized , respectively -LRB- the 1st , 3rd , 14th , 21st , 28th day -RRB-	23681
sham group were collected and homogenized , respectively	23681
sham group	23681
the 1st , 3rd , 14th , 21st , 28th day	23738
The supernatant	23775
the spinal cord of each group , followed by a centrifugation -LRB- 12,000 / g -RRB-	23809
the spinal cord	23809
each group	23828
a centrifugation -LRB- 12,000 / g	23852
a centrifugation	23852
12,000	23870
g	23877
Nanodrop spectrophotometer -LRB- ND-1000 -RRB-	23890
Nanodrop spectrophotometer	23890
ND-1000	23918
the concentrations of RNA samples	23928
the concentrations	23928
RNA samples	23950
The equal amount of RNA -LRB- 4lg -RRB-	23977
The equal amount of RNA	23977
The equal amount	23977
RNA	23997
4lg	24002
each experiment	24020
the β-actin	24043
the internal control	24058
the RT-PCR technique	24080
the level of BDNF mRNA	24128
the level	24128
BDNF mRNA	24141
Gene primers	24152
TaKaRa Company -LRB- Japan -RRB-	24185
TaKaRa Company	24185
Japan	24201
The primer sequences for the upstream and downstream of BDNF	24209
The primer sequences	24209
the upstream and downstream	24234
BDNF	24265
5 ′ TCCCTGGCT GACACTTTT 3 ′ , 5 ′ ATTGGGTAGTTCGGCATT 3 ′ -LRB- the bp is 466 bp -RRB- , while for β-actin is : 5 ′ GTAAAGACCTC TATGCCAACA 3 ′ , 5 ′ GGACTCATCGTACTCCTGCT 3 ′	24288
5 ′ TCCCTGGCT GACACTTTT 3 ′	24288
5 ′ TCCCTGGCT GACACTTTT	24288
3 ′	24311
5 ′ ATTGGGTAGTTCGGCATT 3 ′	24315
5 ′ ATTGGGTAGTTCGGCATT	24315
3 ′	24337
the bp	24341
466 bp	24351
β-actin	24370
5 ′ GTAAAGACCTC TATGCCAACA 3 ′ , 5 ′ GGACTCATCGTACTCCTGCT 3 ′	24383
5 ′ GTAAAGACCTC TATGCCAACA 3 ′	24383
5 ′ GGACTCATCGTACTCCTGCT 3 ′	24412
5 ′ GGACTCATCGTACTCCTGCT	24412
3 ′	24436
the bp	24439
227 bp	24449
Revert AidTM First Strand cDNA Synthesis Kit -LRB- Fermentas , USA -RRB-	24467
Revert AidTM First Strand cDNA Synthesis Kit	24467
Fermentas	24513
USA	24524
the first strand cDNA synthesis	24530
4 μg of total RNA	24580
4 μg	24580
total RNA	24588
RNA	24618
the PCR	24628
the PCR MasterMix Kit -LRB- Fermentas , USA -RRB-	24655
the PCR MasterMix Kit	24655
Fermentas	24678
USA	24689
The whole process for 30 cycles	24695
The whole process	24695
30 cycles	24717
denaturation	24736
1 min at 94 °C , annealing for 1 min , and extension for 1 min	24753
1 min at 94 °C	24753
1 min	24753
94 °C	24762
annealing for 1 min	24768
annealing	24768
1 min	24782
extension for 1 min	24793
extension	24793
1 min	24807
72 °C	24816
the products of PCR	24835
the products	24835
PCR	24851
1 % agarose gel	24879
ethidium bromide	24908
ultraviolet gel imager -LRB- BioRad , USA -RRB-	24949
ultraviolet gel imager	24949
BioRad	24973
USA	24981
The optical density -LRB- OD -RRB- of each product band which consists of objective gene and β-actin	24987
The optical density -LRB- OD -RRB-	24987
The optical density	24987
OD	25008
each product band which consists of objective gene and β-actin	25015
each product band	25015
objective gene and β-actin	25051
the OD ratio between objective genes and β-actin	25101
the OD ratio	25101
objective genes and β-actin	25122
the relative OD values	25178
Western blot analysis The tissues from the injury segments in OECs group ,	25202
Western blot analysis	25202
The tissues from the injury segments	25224
The tissues	25224
the injury segments	25241
OECs group	25264
group and sham one	25285
group	25285
sham one	25295
the 14th day	25307
the 21st day	25325
ice-cold PBS	25390
5 min in lysis buffer -LRB- Pierce -RRB-	25417
5 min	25417
lysis buffer -LRB- Pierce -RRB-	25426
lysis buffer	25426
Pierce	25440
the tissues	25449
12,000 / g	25479
the supernatant	25490
The protein concentrations of the supernatants	25521
The protein concentrations	25521
the supernatants	25551
the micro bicinchoninic acid -LRB- BCA -RRB- method	25592
BCA	25622
Equal amounts of protein -LRB- 20 μg -RRB-	25635
Equal amounts of protein	25635
Equal amounts	25635
protein	25652
20 μg	25661
5 min in Laemmeli buffer	25694
5 min	25694
Laemmeli buffer	25703
12 % SDS-polyacrylamide	25733
nitrocellulose membrane	25778
the membranes	25807
low-fat milk in Trisbuffered saline	25839
low-fat milk	25839
Trisbuffered saline	25855
primary antibodies against rabbit p-ERK -LRB- 1:500 , cell signal -RRB- or ERK -LRB- 1:1000 , cell signal -RRB-	25894
primary antibodies	25894
rabbit p-ERK -LRB- 1:500 , cell signal -RRB- or ERK -LRB- 1:1000 , cell signal -RRB-	25921
rabbit p-ERK	25921
1:500	25935
cell signal	25942
ERK	25958
1:1000	25963
cell signal	25971
HRP-conjugated secondary antibodies -LRB- goat anti-rabbit IgG , 1:5000 -RRB-	26007
HRP-conjugated secondary antibodies	26007
goat anti-rabbit IgG , 1:5000	26044
goat anti-rabbit IgG	26044
1:5000	26066
the labeling	26075
chemiluminescence reagents	26107
the level of ERK and p-ERK	26148
the level	26148
ERK and p-ERK	26161
β-actin	26176
internal control	26196
All pictures	26214
the bands	26246
optical densities	26287
the target band and β-actin ratio	26311
the statistic analysis	26370
Statistical analysis Quantitative variations	26394
mean ± SD	26457
Data	26468
one-way ANOVA	26493
SPSS software package	26510
a suitable correction	26538
The statistical significance	26561
P	26605
